Biolinq Inc
Biolinq Inc. develops the Biolinq Shine™ sensor, which is a fully autonomous, needle-free glucose sensor that integrates glucose, activity, and sleep information.
Funding history
About Biolinq Inc
How much funding has Biolinq Inc raised?
Biolinq Inc has raised $238.0M in total funding. The most recent round was Series C.
Where is Biolinq Inc headquartered?
Biolinq Inc is headquartered in San Diego, CA.
What does Biolinq Inc do?
Biolinq Inc. develops the Biolinq Shine™ sensor, which is a fully autonomous, needle-free glucose sensor that integrates glucose, activity, and sleep information.
What problem does Biolinq Inc solve?
People managing glucose need a way to see real-time, in-context glucose information (tied to activity and sleep) without relying on a needle-based sensor or checking a phone.
What's Biolinq Inc's solution?
Biolinq Shine is a continuous intradermal glucose sensor with a color-changing LED light that shows real-time glucose range, paired with a mobile app that correlates glucose with meals, activity, and sleep.
What makes Biolinq Inc different?
It is described as the first fully autonomous, needle-free glucose sensor, is FDA cleared, and can convey in-range/out-of-range status via its LED light even without a phone present.
What makes Biolinq Inc notable?
Founded in 2012 by two UC San Diego PhD alumni, Jared Tangney and Josh Windmiller, originally under the name Electrozyme.
Leadership
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
